BioMarin Pharmaceutical Inc.
DE ˙ DB ˙ US09061G1013
46,59 € ↑0,90 (1,97%)
2026-06-04
AKTIENPREIS
SecurityDE:BM8 / BioMarin Pharmaceutical Inc.
InstitutionIMA Wealth, Inc.
Latest Disclosed Ownership52 shares
Latest Disclosed Value $ 2,937
IMA Wealth, Inc. reports 3.70% decrease in ownership of BM8 / BioMarin Pharmaceutical Inc.

On May 6, 2026 - IMA Wealth, Inc. filed a 13F-HR form disclosing ownership of 52 shares of BioMarin Pharmaceutical Inc. (DE:BM8) valued at $2,495 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 54 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of -3.70% during the quarter. The current value of the position is $2,423 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F BioMarin Pharmaceutical Common Stock 09061G101 52 -2 -3.70 3 -33.33 0.0003
2026-02-11 2025-12-31 13F BioMarin Pharmaceutical Common Stock 09061G101 54 54 3 0.0003
2022-06-13 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -1,500 -100.00 0 -100.00
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 1,500 -32,048 -95.53 133 -94.87 0.0294
2021-11-03 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 33,548 1,092 3.36 2,593 -4.25 0.6125
2021-08-13 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,456 -426 -1.30 2,708 9.06 0.6328
2021-05-13 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 32,882 7,350 28.79 2,483 10.90 0.6083
2021-02-08 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 25,532 -8,553 -25.09 2,239 -13.65 0.6277
2020-11-16 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 34,085 5,151 17.80 2,593 -27.35 0.8694
2020-08-13 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 28,934 -10,298 -26.25 3,569 7.66 1.2904
2020-04-14 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 39,232 -2,008 -4.87 3,315 -4.93 1.4589
2020-02-24 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 41,240 521 1.28 3,487 27.08 1.2942
2019-10-29 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 40,719 3,353 8.97 2,744 -14.25 1.0364
2019-07-19 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 37,366 -2,293 -5.78 3,200 -9.17 1.1964
2019-05-09 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 39,659 704 1.81 3,523 6.21 1.3676
2019-01-15 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 38,955 941 2.48 3,317 -10.01 1.5476
2018-10-18 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 38,014 2,876 8.18 3,686 11.36 1.4414
2018-08-01 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 35,138 417 1.20 3,310 17.58 1.3790
2018-04-20 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 34,721 34,721 2,815 1.2530
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.